title: Impact of left ventricular lead position on the efficacy of cardiac resynchronisation therapy: a two-dimensional strain echocardiography study.
abstract: BACKGROUND
  Definition of the optimal left ventricular (LV) lead position in cardiac resynchronisation therapy (CRT) is desirable.
  
  
  OBJECTIVE
  To define the optimal LV lead position in CRT and assess the effectiveness of CRT depending on the LV lead position using new myocardial deformation imaging.
  
  
  METHODS
  Myocardial deformation imaging based on tracking of acoustic tissue pixels in two-dimensional echocardiographic images (EchoPAC, GE ultrasound) was performed in 47 patients with heart failure at baseline and during CRT. In a 36-segment LV model the segment with the latest peak systolic circumferential strain before CRT was determined. The segment with maximal temporal difference in peak systolic circumferential strain on CRT compared with before CRT was assumed to be the LV lead position. The optimal LV lead position was defined as concurrence or immediate neighbouring of the segment with the latest contraction before CRT and those with assumed LV lead location.
  
  
  RESULTS
  25 patients had optimal and 22 non-optimal LV lead positions. Before CRT, the LV ejection fraction (EF) and peak oxygen consumption (Vo2max) were similar in patients with optimal and non-optimal LV lead positions (mean (SD) EF = 31.4 (6.1)% vs 30.3 (6.5)% and Vo2max = 14.2 (1.8) vs 14.0 (2.1) ml/min/kg, respectively). At 3 months on CRT, EF increased by 9 (2)% vs 5 (3)% and Vo2max by 2.0 (0.8) vs 1.1 (0.5) ml/min/kg in the optimal vs non-optimal LV lead position groups, respectively (both p<0.001).
  
  
  CONCLUSIONS
  Concordance of the LV lead site and location of the latest systolic contraction before CRT results in greater improvement in EF and cardiopulmonary workload than the non-optimal LV lead position.
authors.affiliation: University RWTH Aachen, Department of Cardiology, Aachen, Germany.
authors.forename: Michael
authors.initials: M
authors.lastname: Becker
authors.forename: Andreas
authors.initials: A
authors.lastname: Franke
authors.forename: Ole A
authors.initials: OA
authors.lastname: Breithardt
authors.forename: Christina
authors.initials: C
authors.lastname: Ocklenburg
authors.forename: Theresa
authors.initials: T
authors.lastname: Kaminski
authors.forename: Rafael
authors.initials: R
authors.lastname: Kramann
authors.forename: Christian
authors.initials: C
authors.lastname: Knackstedt
authors.forename: Christoph
authors.initials: C
authors.lastname: Stellbrink
authors.forename: Peter
authors.initials: P
authors.lastname: Hanrath
authors.forename: Patrick
authors.initials: P
authors.lastname: Schauerte
authors.forename: Rainer
authors.initials: R
authors.lastname: Hoffmann
mesh_terms: D002304:Cardiac Pacing, Artificial; D004452:Echocardiography; D004566:Electrodes; D005260:Female; D006333:Heart Failure / Q000628:therapy*; D006352:Heart Ventricles; D006801:Humans; D008297:Male; D008875:Middle Aged; D009200:Myocardial Contraction / Q000502:physiology; D010101:Oxygen Consumption; D010138:Pacemaker, Artificial